Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Pediatric Radiology
Erschienen in: Pediatric Radiology 1/2019

17.09.2018 | Review

Imaging findings of sterile pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome: differential diagnosis and review of the literature

verfasst von: Claudia Martinez-Rios, Mehul P. Jariwala, Kerri Highmore, Karen Watanabe Duffy, Lynn Spiegel, Ronald M. Laxer, Jennifer Stimec

Erschienen in: Pediatric Radiology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome is a rare autosomal-dominant autoinflammatory disease of incomplete penetrance and variable expression. PAPA syndrome is the result of a mutation in the proline serine threonine phosphatase-interacting protein 1 (PSTPIP1/CD2BP1) gene located on chromosome 15, which results in an abnormal overproduction of the pro-inflammatory cytokine interleukin-1β (IL-1). This syndrome clinically manifests as early onset of recurrent episodes of acute aseptic inflammation of the joints, generally occurring in the first two decades of life, followed by manifestation of characteristic skin lesions in the third decade, after an obvious decline in the joint symptoms. Although uncommon, the potential clinical implications of PAPA syndrome warrant an appropriate diagnosis in a timely fashion.
Literatur
1.
Demidowich AP, Freeman AF, Kuhns DB et al (2012) Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Arthritis Rheum 64:2022–2027CrossRefPubMed
2.
Wise CA, Gillum JD, Seidman CE et al (2002) Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 11:961–969CrossRefPubMed
3.
Yeon HB, Lindor NM, Seidman JG et al (2000) Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet 66:1443–1448CrossRefPubMedPubMedCentral
4.
Wang D, Höing S, Patterson HC et al (2013) Inflammation in mice ectopically expressing human pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome-associated PSTPIP1 A230T mutant proteins. J Biol Chem 288:4594–4601CrossRefPubMedPubMedCentral
5.
Lindor NM, Arsenault TM, Solomon H et al (1997) A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 72:611–615CrossRefPubMed
6.
7.
8.
Smith EJ, Allantaz F, Bennet L et al (2010) Clinical, molecular, and genetic characteristics of PAPA syndrome: a review. Curr Genomics 11:519–527CrossRefPubMedPubMedCentral
9.
Loffler W, Lohse P, Weihmayr T et al (2017) Pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome: differential diagnosis of septic arthritis by regular detection of exceedingly high synovial counts. Infection 45:395–402CrossRefPubMed
10.
Holzinger D, Roth J (2016) Alarming consequences — autoinflammatory disease spectrum due to mutations in proline-serine threonine phosphatase-interacting protein 1. Curr Opin Rheumatol 28:550–559CrossRefPubMed
11.
Fathalla BM, Al-Wahadneh AM, Al-Mutawa M et al (2014) A novel de novo PSTPIP1 mutation in a boy with pyogenic arthritis, pyoderma gangrenosum, acne (PAPA) syndrome. Clin Exp Rheumatol 32:956–958PubMed
12.
Wise CA, Bennet LB, Pascual V et al (2000) Localization of a gene for familial recurrent arthritis 43:2041–2045
13.
Cortis E, Benedetti DF, Insalaco A et al (2004) Abnormal production of the tumor necrosis factor inhibitor etanercept and clinical efficacy of tumor in a patient with PAPA syndrome. J Pediatr 145:851–855CrossRefPubMed
14.
Dierselhuis MP, Frenkel J, Wulffraat NM et al (2005) Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatology 44:406–408CrossRefPubMed
15.
Brenner M, Ruzicka G, Plewig G (2009) Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol 161:1199–1201CrossRefPubMed
16.
Tofteland ND, Shaver TS (2010) Clinical efficacy of etanercept for treatment of PAPA syndrome. J Clin Rheumatol 16:244–245CrossRefPubMed
17.
Schellevis MA, Stoffels M, Hoppenreijs EPAH et al (2011) Variable expression and treatment of PAPA syndrome. Ann Rheum Dis 70:1168–1170CrossRefPubMed
18.
Caorsi R, Picco P, Buoncompagni A et al (2014) Osteolytic lesion in PAPA syndrome responding to anti-interleukin 1 treatment. J Rheumatol 41:2333–2334CrossRefPubMed
19.
Omenetti A, Carta S, Caorsi R et al (2016) Disease activity accounts for long-term efficacy of IL-1 blockers in pyogenic sterile arthritis pyoderma gangrenosum and severe acne syndrome. Rheumatology 55:1325–1335CrossRefPubMed
20.
Jacobs JC, Goetzi EJ (1975) Streaking leukocyte factor, arthritis, and pyoderma gangrenosum. Pediatrics 56:570–578PubMed
21.
Shoham NG, Centola M, Mansfield E et al (2003) Pyrin binds PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci U S A 100:13501–13506CrossRefPubMedPubMedCentral
22.
McDermott MF (2004) A common pathway in periodic fever syndromes. Trends Immunol 25:457–460CrossRefPubMed
23.
Omenetti A, Caorsi R, Carta S et al (2013) PW02-006-PAPA syndrome clinical spectrum and IL1B release. Pediatr Rheumatol 11:A146CrossRef
24.
Caorsi R, Marotto D, Insalaco A et al (2015) The phenotypic variability of PAPA syndrome: evidence from the Eurofever registry. Pediatr Rheumatol 13:08CrossRef
25.
Yang H, Reinherz EL (2006) CD2BP1 modulates CD2-dependent T cell activation via linkage to protein tyrosine phosphatase (PTP)-PEST. J Immunol 176:5898–5907CrossRefPubMed
26.
Starnes TW, Bennin DA, Bing X et al (2014) The F-BAR protein PSTPIP1 controls extracellular matrix degradation and filopodia formation in macrophages. Blood 123:2703–2714CrossRefPubMedPubMedCentral
27.
Yu JW, Wu J, Zhang Z et al (2006) Cryopyrin and pyrin activate caspase-1, but not NF-kappa B, via ASC oligomerization. Cell Death Differ 13:236–249CrossRefPubMed
28.
Arostegui JI, Yagüe J (2008) Hereditary systemic autoinflammatory diseases. Part II: cryopyrin-associated periodic syndromes, pediatric systemic granulomatosis and PAPA syndrome. Med Clin 130:429–438CrossRef
29.
Braun-Falco M, Kovnerystyy O, Lohse P et al (2012) Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol 66:409–415CrossRefPubMed
30.
Lambertucci JR (2014) Fever of undetermined origin in a patient with pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA syndrome). Rev Soc Bras Med Trop 47:122CrossRefPubMed
31.
Marzano AV, Borghi A, Meroni PL et al (2016) Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation. Br J Dermatol 175:882–891CrossRefPubMed
32.
Varga G, Gattorno M, Foell D et al (2015) Redox distress and genetic defects conspire in systemic autoinflammatory diseases. Nat Rev Rheumatol 11:670–680CrossRefPubMed
33.
Löhrer R, Eming R, Wolfrum N et al (2011) Autoinflammatory diseases as cause of wound healing defects. Hautarzt 62:524–533CrossRefPubMed
34.
Verbsky JW (2012) Monogenic causes of inflammatory disease in rheumatology. Curr Opin Rheumatol 24:506–514CrossRefPubMed
35.
Caso F, Rigante D, Vitale A (2013) Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. Int J Rheumatol 2013:513782CrossRefPubMedPubMedCentral
36.
Thacker PG, Binkovitz LA, Thomas KB (2012) Deficiency of interleukin-1-receptor antagonist syndrome: a rare auto-inflammatory condition that mimics multiple classic radiographic findings. Pediatr Radiol 42:495–498CrossRefPubMed
37.
Aksentijevich I, Masters SL, Ferguson PJ et al (2009) An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 360:2426–2437CrossRefPubMedPubMedCentral
38.
Stenerson M, Dufendach K, Aksentijevich I (2011) The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist. Arthritis Rheum 63:4018–4022CrossRefPubMed
39.
Daldrup-Link HE, Steinbach L (2009) MR imaging of pediatric arthritis. Magn Reson Imaging Clin N Am 17:451–467CrossRefPubMed
40.
Macaubas C, Nguyen K, Milojevic D et al (2009) Oligoarticular and polyarticular JIA: epidemiology and pathogenesis. Nat Rev Rheumatol 5:616–626CrossRefPubMedPubMedCentral
41.
Oberle EJ, Harris JG, Verbsky JW (2014) Polyarticular juvenile idiopathic arthritis-epidemiology and management approaches. J Clin Epidemiol 6:379–393
42.
Monsalve J, Kan JH (2015) Septic arthritis in children: frequency of coexisting unsuspected osteomyelitis and implications on imaging work-up and management. AJR Am J Roentgenol 204:1289–1295CrossRefPubMed
43.
Karchevsky M, Schweitzer ME, Morrison WB et al (2004) MRI findings of septic arthritis and associated osteomyelitis in adults. AJR Am J Roentgenol 182:119–122CrossRefPubMed
44.
Funk SS, Copley LAB (2017) Acute hematogenous osteomyelitis in children. Pathogenesis, diagnosis and treatment. Orthop Clin N Am 48:199–208CrossRef
45.
46.
Ferguson PJ, Sandu M (2012) Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep 14:130–141CrossRefPubMedPubMedCentral
47.
Ferguson PJ, Chen S, Tayeh MK et al (2005) Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 42:551–557CrossRefPubMedPubMedCentral
48.
Chen W, Obermayer-Pietsch B, Hong JB (2011) Acne-associated syndromes: models for better understanding of acne pathogenesis. J Eur Acad Dermatol Venereol 25:637–646CrossRefPubMed
49.
Stichweh DS, Punaro M, Pascual V (2005) Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Pediatr Dermatol 22:262–265CrossRefPubMed
50.
51.
Horiuchi I, Fukatsu Y, Ushijima J et al (2016) A pregnancy-associated nonfamilial case of PAPA (pyogenic sterile arthritis, pyoderma gangrenosum, acne) syndrome. Clin Case Rep 4:989–991CrossRefPubMedPubMedCentral
52.
Hong J, Su Y, Chiu H (2009) Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome): report of a sporadic case without an identifiable mutation in the CD2BP1 gene. J Am Acad Dermatol 61:533–535CrossRefPubMed
53.
Nguyen MT, Borchers A, Selmi C et al (2012) The SAPHO syndrome. Semin Arthritis Rheum 42:254–265CrossRefPubMed
54.
Basmaci R, Bonacorsi S (2017) Kingella kingae: from carriage to infection. Commentary on Canadian Medical Association Journal. CMAJ 189:E1105–E1106CrossRefPubMedPubMedCentral
55.
Edrees AF, Kaplan DL, Abdou NI (2002) Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) associated with hypogammaglobulinemia and elevated serum tumor necrosis factor-a levels. J Clin Rheumatol 8:273–275CrossRefPubMed
56.
Finetti M, Caorsi R, Marotto D et al (2015) Long-term efficacy of IL-1 blockers in PAPA patients. Pediatr Rheumatol 13:P207CrossRef
57.
Gattorno M, Tassi S, Carta S et al (2007) Pattern of interleukin-1 beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum 56:3138–3148CrossRefPubMed
58.
Geusau A, Mothes-Luksch N, Nahavandi H et al (2013) Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment. JAMA Dermatol 149:209–215CrossRefPubMed
59.
Ter Haar N, Lachmann H, Özen S et al (2013) Treatment of autoinflammatory diseases: results from the Eurofever registry and a literature review. Ann Rheum Dis 72:678–685CrossRefPubMed
60.
Stone D, Ombrello A, Almeida ADJ et al (2015) Use of TNF inhibitors in the treatment of PAPA syndrome. Pediatr Rheumatol 13:P138CrossRef
61.
Lee H, Park SH, Kim SK (2012) Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) with E250K mutation in CD2BP1 gene treated with the tumor necrosis factor inhibitor adalimumab. Clin Exp Rheumatol 30:452PubMed
Metadaten
Titel
Imaging findings of sterile pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome: differential diagnosis and review of the literature
verfasst von
Claudia Martinez-Rios
Mehul P. Jariwala
Kerri Highmore
Karen Watanabe Duffy
Lynn Spiegel
Ronald M. Laxer
Jennifer Stimec
Publikationsdatum
17.09.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 1/2019
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-018-4246-1

Weitere Artikel der Ausgabe 1/2019

Pediatric Radiology 1/2019 Zur Ausgabe

Original Article

Technical success and outcomes in pediatric patients undergoing transjugular intrahepatic portosystemic shunt placement: a 20-year experience

Review

Differential diagnosis of perinatal hypophosphatasia: radiologic perspectives

Original Article

Performance of two--dimensional ultrasound shear wave elastography: reference values of normal liver stiffness in children

Exposure

ᅟ

Original Article

4-D flow MRI aortic 3-D hemodynamics and wall shear stress remain stable over short-term follow-up in pediatric and young adult patients with bicuspid aortic valve

Letter to the Editor

Diagnostic efficacy of single-pass split-bolus multidetector computed tomography in pediatric oncology: a valid alternative to a standard monophasic protocol

Neu im Fachgebiet Radiologie

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise